treatment of vaginal atrophy in women with a risk of cardiovascular disease

摘要

the present invention relates to the use of estriol in the preparation of a pharmaceutical formulation for vaginal administration, with the capability of self limiting absorption of estriol.the development is aimed at the prevention and / or treatment of urogenital atrophy in women with a high probability of suffering from cardiovascular disease, or suffer or have suffered from heart disease.